Barbara Dalton

Barbara Dalton

Corporate Officer/Principal bei PFIZER INC.
71 Jahre
Health Technology
Finance
Commercial Services

Profil

Barbara J.
Dalton
currently works at Terragen Discovery, Inc., as Director, Second Genome, Inc., as Director, Cydan LLC, as Director, Ixchelsis Ltd., as Director, Penn State Research Foundation, as Director, Advanced MR Analytics AB, as Director, Petra Pharma Corp., as Director, Priovant Therapeutics, Inc., as Director, Alzheimer's Disease Research Foundation, as Director, Pfizer Inc., as Vice President-Worldwide Business Development from 2007, Pfizer Venture Investments LLC, as Vice President & Senior Managing Partner from 2012, and The New York City Investment Fund Manager, Inc., as Advisor.
Dr. Dalton also formerly worked at Scimagix, Inc., as Chairman, Aspira Women's Health, Inc., as Director, Celladon Corp., as Independent Director in 2014, Complexa, Inc., as Director, Artios Pharma Ltd., as Director, Ijetset Corp., as Director, Physiome Sciences, Inc., as Director, Gryphon Therapeutics, Inc., as Director, Melinta Subsidiary Corp., as Director, National Venture Capital Association, as Director, New York Biotechnology Association, Inc., as Director, Ablexis LLC, as Director, Cydan II, Inc., as Director, Vtesse, Inc., as Director, Lodo Therapeutics Corp., as Director, Imara, Inc., as Independent Director, Morphic Holding, Inc., as Director, Tiburio Therapeutics, Inc., as Director, GSK Equity Investments Ltd, as President from 1993 to 2003, EuclidSR Partners, as Partner from 2005 to 2007, and SR One Capital Management LP, as President from 1993 to 2003.
Dr. Dalton received her doctorate degree in 1983 from Drexel University College of Medicine and undergraduate degree from Eberly College of Science.

Aktive Positionen von Barbara Dalton

UnternehmenPositionBeginn
PFIZER INC. Corporate Officer/Principal 01.01.2007
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Berater -
Direktor/Vorstandsmitglied -
Private Equity Investor 01.09.2007
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -

Ehemalige bekannte Positionen von Barbara Dalton

UnternehmenPositionEnde
░░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Barbara Dalton im Detail an

Ausbildung von Barbara Dalton

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

71

Beziehungen ersten Grades

35

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen35

Health Technology

Health Technology

Health Technology

Finance

Finance

Health Technology

Commercial Services

Commercial Services

Health Technology

Finance

Health Technology

Finance

Finance

Commercial Services

Commercial Services

Health Technology

Technology Services

Health Technology

Consumer Services

Health Technology

Distribution Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Miscellaneous

  1. Börse
  2. Insiders
  3. Barbara Dalton